Medeon Biodesign, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 139.002 million compared to TWD 111.835 million a year ago. Operating loss was TWD 39.605 million compared to TWD 66.642 million a year ago. Net loss was TWD 62.031 million compared to TWD 55.984 million a year ago. Basic loss per share was TWD 0.94 compared to TWD 0.84 a year ago. For the half year, sales was TWD 276.022 million compared to TWD 206.427 million a year ago. Operating loss was TWD 82.202 million compared to TWD 127.285 million a year ago. Net loss was TWD 115.533 million compared to TWD 108.708 million a year ago. Basic loss per share was TWD 1.74 compared to TWD 1.66 a year ago.